REVLIMID Adverse Event: Pulmonary embolism
REVLIMID Adverse Event: Pulmonary embolism is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: REVLIMID; Product category: Drug; Primary reaction: Pulmonary embolism.
| Primary drug | REVLIMID |
|---|---|
| Product category | Drug |
| Primary reaction | Pulmonary embolism |
| All reactions | Pulmonary embolism; Gastroenteritis; Dehydration |
| Seriousness | Serious |
| Patient outcome | Unknown |
| Patient sex | Female |
| All drugs reported | REVLIMID; REVLIMID; REVLIMID |
| Reporter country | US |
| Reporter type | 1 |
| Report date | 20140312 |
| Report ID | 10005111 |
$299/mo
Try FDATracker →